Free Trial
OTC:NVZMY

Novonesis A/S (NVZMY) Stock Price, News & Analysis

Novonesis A/S logo
$61.16 +2.44 (+4.16%)
As of 03:59 PM Eastern

About Novonesis A/S Stock (OTC:NVZMY)

Key Stats

Today's Range
$59.59
$62.40
50-Day Range
$55.74
$62.57
52-Week Range
$52.96
$72.50
Volume
31,073 shs
Average Volume
19,484 shs
Market Capitalization
$28.64 billion
P/E Ratio
38.71
Dividend Yield
2.45%
Price Target
N/A
Consensus Rating
Sell

Company Overview

Novonesis A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, microbial and medical cleaning services. Further, it provides corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions, comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, education, wastewater, and sewage sludge, and renewable diesel solutions; agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, diagnostics, enzyme, and biogas solutions. Furthermore, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novonesis A/S was founded in 1925 and is based in Bagsvaerd, Denmark.

Remove Ads
Receive NVZMY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novonesis A/S and its competitors with MarketBeat's FREE daily newsletter.

NVZMY Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

NVZMY Stock Analysis - Frequently Asked Questions

Novonesis A/S's stock was trading at $56.5399 at the beginning of the year. Since then, NVZMY stock has increased by 8.2% and is now trading at $61.16.
View the best growth stocks for 2025 here
.

Shares of NVZMY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
4/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTC
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
OTC:NVZMY
Employees
6,756
Year Founded
N/A

Profitability

Trailing P/E Ratio
38.71
Forward P/E Ratio
34.75
P/E Growth
2.79
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.60 billion
Cash Flow
$1.03 per share
Price / Cash Flow
59.50
Book Value
$4.45 per share
Price / Book
13.74

Miscellaneous

Free Float
N/A
Market Cap
$28.64 billion
Optionable
N/A
Beta
0.91
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (OTC:NVZMY) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners